May 2017: Recommendation 1.5.11 was amended to add a link to NICE's technology appraisal guidance on nintedanib for the treatment of idiopathic pulmonary fibrosis. Two outdated recommendations for research were removed.
Minor changes since publication
October 2022: We added text to indicate that pulse oximetry may be less reliable in people with dark skin. We also added a link to the NHS patient safety alert on the risk of harm from inappropriate placement of pulse oximeter probes. See recommendation 1.5.1.